Apeiron RIA’s Abiomed Inc ABMD Stock Holding History

Apeiron RIA’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-407	Closed	-$1.01K	–	220
2022 Q2	$1.01K	Buy	+407	New	+$110K	0.28%	40

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Apeiron RIA's ABMD Position: Q3 2022 in Review

Apeiron RIA sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 407 shares — an estimated $1.01K sold.

Apeiron RIA first reported a position in ABMD in Q2 2022 and held it in 1 quarter. The position peaked at $1.01K in Q2 2022. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

Apeiron RIA reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
Apeiron RIA sold 407 Abiomed Inc shares in Q3 2022, an estimated $1.01K.
Apeiron RIA first reported a position in Abiomed Inc in Q2 2022 and held it in 1 quarter.
Apeiron RIA's Abiomed Inc position peaked at $1.01K in Q2 2022.
517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Apeiron RIA's 13F filing for Q3 2022, filed 18 Oct 2022.